Open AccessAntitumor activity of the ERK inhibitor DEL22379 against BRAF-like cells in thyroid cancer.
Author(s) -
Adrián Acuña-Ruíz,
Miguel A. Zaballos,
Pilar Santisteban,
Garcilaso RiescoEizaguirre,
Piero Crespo,
Adrián Acuña-Ruíz,
Miguel A. Zaballos,
Pilar Santisteban,
Garcilaso RiescoEizaguirre,
Piero Crespo
Publication year - 2019
Publication title -
ibj plus
Language(s) - English
Resource type - Journals
ISSN - 2531-0151
DOI - 10.24217/2531-0151.19v1s3.00046
Subject(s) - thyroid cancer , mapk/erk pathway , cancer research , cancer , thyroid , medicine , oncology , endocrinology , biology , kinase , microbiology and biotechnology